Literature DB >> 17534267

Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect.

Abbas Nikravesh1, Rikard Dryselius, Omid R Faridani, Shan Goh, Majid Sadeghizadeh, Mehrdad Behmanesh, Anita Ganyu, Erik Jan Klok, Rula Zain, Liam Good.   

Abstract

Antisense agents that target growth-essential genes display surprisingly potent bactericidal properties. In particular, peptide nucleic acid (PNA) and phosphorodiamidate morpholino oligomers linked to cationic carrier peptides are effective in time kill assays and as inhibitors of bacterial peritonitis in mice. It is unclear how these relatively large antimicrobials overcome stringent bacterial barriers and mediate killing. Here we determined the transit kinetics of peptide-PNAs and observed an accumulation of cell-associated PNA in Escherichia coli and slow efflux. An inhibitor of drug efflux pumps did not alter peptide-PNA potency, indicating a lack of active efflux from cells. Consistent with cell retention, the post-antibiotic effect (PAE) of the anti-acyl carrier protein (acpP) peptide-PNA was greater than 11 hours. Bacterial cell accumulation and a long PAE are properties of significant interest for antimicrobial development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534267     DOI: 10.1038/sj.mt.6300209

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  23 in total

1.  Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria.

Authors:  Alfonso J C Soler Bistué; Fernando A Martín; Nicolás Vozza; Hongphuc Ha; Jonathan C Joaquín; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

2.  Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.

Authors:  Ying Zhou; Zheng Hou; Chao Fang; Xiaoyan Xue; Fei Da; Yukun Wang; Hui Bai; Xiaoxing Luo
Journal:  Folia Microbiol (Praha)       Date:  2012-06-09       Impact factor: 2.099

Review 3.  Bacterial antisense RNAs: how many are there, and what are they doing?

Authors:  Maureen Kiley Thomason; Gisela Storz
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

4.  Improved templated fluorogenic probes enhance the analysis of closely related pathogenic bacteria by microscopy and flow cytometry.

Authors:  Raphael M Franzini; Eric T Kool
Journal:  Bioconjug Chem       Date:  2011-08-26       Impact factor: 4.774

5.  Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa.

Authors:  Anubrata Ghosal; Peter E Nielsen
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486

6.  Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids.

Authors:  Huijuan Wang; Yunyan He; Yun Xia; Lipeng Wang; Shumei Liang
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

Review 7.  Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages.

Authors:  Remo George; Renata Cavalcante; Celso Carvalho; Elyana Marques; Jonathan B Waugh; M Tino Unlap
Journal:  World J Exp Med       Date:  2015-08-20

8.  Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria.

Authors:  Kristen A Eller; Thomas R Aunins; Colleen M Courtney; Jocelyn K Campos; Peter B Otoupal; Keesha E Erickson; Nancy E Madinger; Anushree Chatterjee
Journal:  Commun Biol       Date:  2021-03-12

9.  Synthetic RNA silencing in bacteria - antimicrobial discovery and resistance breaking.

Authors:  Liam Good; James E M Stach
Journal:  Front Microbiol       Date:  2011-09-12       Impact factor: 5.640

10.  Internalization of Locked Nucleic Acids/DNA Hybrid Oligomers into Escherichia coli.

Authors:  German M Traglia; Carol Davies Sala; Juan I Fuxman Bass; Alfonso J C Soler-Bistué; Angeles Zorreguieta; María Soledad Ramírez; Marcelo E Tolmasky
Journal:  Biores Open Access       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.